Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic
The relentless progress of medical technology regularly unlocks new arenas in the battle against disease, with one of the most notable being the potent capabilities of Natural Killer (NK) cell therapies. As critical members of the immune system, NK cells have become the cornerstone of an innovative
In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a cautious stance
In the bustling bio-cluster of Genome Valley, Hyderabad, sits a new beacon of innovation: Aurigene Pharmaceutical Services' sprawling 70,000-square-foot biologics facility. This strategic extension, an affiliate of Dr. Reddy’s Laboratories, heralds a new era for biopharmaceutical development and
The biotech startup Limula, founded in 2020, has announced the triumphant completion of a seed funding round, obtaining a significant $6.8 million. This investment is a clear indication of the potential seen in Limula's groundbreaking approach to cell and gene therapy. With such therapies typically
Engineered T-cell receptor (TCR) therapies hold a promising future in the realm of oncology, particularly for solid tumors—long considered a formidable adversary due to their complex microenvironment. In a strategic move, AmplifyBio and Xcell Biosciences have joined forces with a shared vision of
